Effect of prior treatments on post-cdk 4/6 inhibitor survival in hormone receptor-positive breast cancer
HIGHLIGHTS who: Jeffrey Franks from the Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, […]